GLOBAL LONGITUDINAL STRAIN AND 3D ECHOCARDIOGRAPHY FOR EARLY DETECTION OF ANTHRACYCLINE-INDUCED SUBCLINICAL CARDIOTOXICITY: NARRATIVE REVIEW
Abstract
Introduction and purpose: Anthracyclines are highly effective chemotherapeutic agents but carry a significant risk of dose-dependent cardiac toxicity, often progressing silently before left-ventricular ejection fraction (LVEF) declines. The objective of this review was to evaluate the role of three-dimensional echocardiography (3D-ECHO) and global longitudinal strain (GLS) in the early detection of subclinical anthracycline-induced cardiotoxicity and to compare their diagnostic performance with conventional 2D-LVEF assessment.
Methods: A narrative review was conducted using clinical and observational studies indexed in PubMed over the last ten years. Only peer-reviewed human research evaluating anthracycline-induced cardiotoxicity was included. Studies comparing 2D-LVEF with 3D-LVEF and/or global longitudinal strain (GLS), as well as those assessing early markers of subclinical left-ventricular dysfunction, were selected. Extracted data focused on diagnostic effectiveness, time-to-detection of myocardial injury, and prognostic relevance of strain-based parameters.
Conclusion: GLS and 3D-echocardiography outperform conventional 2D-LVEF in identifying early, subclinical anthracycline-related cardiotoxicity. GLS provides the highest sensitivity for early myocardial injury, while 3D-STE enhances spatial assessment and detects dysfunction before EF decline. Routine integration of these modalities into cardio-oncology surveillance may enable earlier intervention, prevent irreversible damage, and improve long-term cardiac outcomes.
References
Camilli, M., Cipolla, C. M., Dent, S., Minotti, G., & Cardinale, D. M. (2024). Anthracycline Cardiotoxicity in Adult Cancer Patients: JACC: CardioOncology State-of-the-Art Review. JACC. CardioOncology, 6(5), 655–677. https://doi.org/10.1016/j.jaccao.2024.07.016
Cardinale, D., Iacopo, F., & Cipolla, C. M. (2020). Cardiotoxicity of Anthracyclines. Frontiers in cardiovascular medicine, 7, 26. https://doi.org/10.3389/fcvm.2020.00026
Zhang, L., Zhang, R., Shuai, P., Chen, J., & Yin, L. (2022). A global case meta-analysis of three-dimensional speckle tracking for evaluating the cardiotoxicity of anthracycline chemotherapy in breast cancer. Frontiers in cardiovascular medicine, 9, 942620. https://doi.org/10.3389/fcvm.2022.942620
Faggiano, A., Gherbesi, E., Giordano, C., Gamberini, G., Vicenzi, M., Cuspidi, C., Carugo, S., Cipolla, C. M., & Cardinale, D. M. (2024). Anthracycline-Induced Subclinical Right Ventricular Dysfunction in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Cancers, 16(22), 3883. https://doi.org/10.3390/cancers16223883
Qiu, S., Zhou, T., Qiu, B., Zhang, Y., Zhou, Y., Yu, H., Zhang, J., Liu, L., Yuan, L., Yang, G., Duan, Y., & Xing, C. (2021). Risk Factors for Anthracycline-Induced Cardiotoxicity. Frontiers in cardiovascular medicine, 8, 736854. https://doi.org/10.3389/fcvm.2021.736854
Herrmann, J., Lenihan, D., Armenian, S., Barac, A., Blaes, A., Cardinale, D., Carver, J., Dent, S., Ky, B., Lyon, A. R., López-Fernández, T., Fradley, M. G., Ganatra, S., Curigliano, G., Mitchell, J. D., Minotti, G., Lang, N. N., Liu, J. E., Neilan, T. G., Nohria, A., … Valent, P. (2022). Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European heart journal, 43(4), 280–299. https://doi.org/10.1093/eurheartj/ehab674
Contaldi, C., D’Aniello, C., Panico, D., Zito, A., Calabrò, P., Di Lorenzo, E., Golino, P., & Montesarchio, V. (2025). Cancer-Therapy-Related Cardiac Dysfunction: Latest Advances in Prevention and Treatment. Life, 15(3), 471. https://doi.org/10.3390/life15030471
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., Lopez Fernandez, T., Mohty, D., Piepoli, M. F., Tamargo, J., Torbicki, A., Suter, T. M., & ESC Scientific Document Group (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European heart journal, 37(36), 2768–2801. https://doi.org/10.1093/eurheartj/ehw211
Zhou, F., Niu, L., Zhao, M., Ni, W. X., & Liu, J. (2020). Real-time three-dimensional echocardiography predicts cardiotoxicity induced by postoperative chemotherapy in breast cancer patients. World journal of clinical cases, 8(12), 2542–2553. https://doi.org/10.12998/wjcc.v8.i12.2542
Zhang, K. W., Finkelman, B. S., Gulati, G., Narayan, H. K., Upshaw, J., Narayan, V., Plappert, T., Englefield, V., Smith, A. M., Zhang, C., Hundley, W. G., & Ky, B. (2018). Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction. JACC. Cardiovascular imaging, 11(8), 1059–1068. https://doi.org/10.1016/j.jcmg.2018.01.015
Muraru, D., Niero, A., Rodriguez-Zanella, H., Cherata, D., & Badano, L. (2018). Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovascular diagnosis and therapy, 8(1), 101–117. https://doi.org/10.21037/cdt.2017.06.01
Poon, J., Leung, J. T., & Leung, D. Y. (2019). 3D Echo in Routine Clinical Practice - State of the Art in 2019. Heart, lung & circulation, 28(9), 1400–1410. https://doi.org/10.1016/j.hlc.2019.04.003
Baldea, S. M., Velcea, A. E., Rimbas, R. C., Andronic, A., Matei, L., Calin, S. I., Muraru, D., Badano, L. P., & Vinereanu, D. (2021). 3-D Echocardiography Is Feasible and More Reproducible than 2-D Echocardiography for In-Training Echocardiographers in Follow-up of Patients with Heart Failure with Reduced Ejection Fraction. Ultrasound in medicine & biology, 47(3), 499–510. https://doi.org/10.1016/j.ultrasmedbio.2020.10.022
Piveta, R. B., Rodrigues, A. C. T., Vieira, M. L. C., Fischer, C. H., Afonso, T. R., Daminello, E., Cruz, F. M., Galvão, T. F. G., Filho, E. B. L., Katz, M., i Morhy, S. S. (2022). Wczesna zmiana odkrężenia powierzchniowego wykryta przez śledzenie plamek 3D jest związana z późniejszą kardiotoksycznością u pacjentów leczonych niskimi dawkami antracyklin. Granice medycyny sercowo-naczyniowej, 9, 842532. https://doi.org/10.3389/fcvm.2022.842532
Yeong, C. C., Harrop, D. L., Ng, A. C. T., & Wang, W. Y. S. (2024). Global longitudinal strain manually measured from mid-myocardial lengths is a reliable alternative to speckle tracking global longitudinal strain. Journal of cardiovascular imaging, 32(1), 35. https://doi.org/10.1186/s44348-024-00038-x
Sławiński, G., Hawryszko, M., Liżewska-Springer, A., Nabiałek-Trojanowska, I., & Lewicka, E. (2023). Global Longitudinal Strain in Cardio-Oncology: A Review. Cancers, 15(3), 986. https://doi.org/10.3390/cancers15030986
Thavendiranathan, P., Poulin, F., Lim, K. D., Plana, J. C., Woo, A., & Marwick, T. H. (2014). Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. Journal of the American College of Cardiology, 63(25 Pt A), 2751–2768. https://doi.org/10.1016/j.jacc.2014.01.073
Araujo-Gutierrez, R., Chitturi, K. R., Xu, J., Wang, Y., Kinder, E., Senapati, A., Chebrolu, L. B., Kassi, M., & Trachtenberg, B. H. (2021). Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity. Cardio-oncology (London, England), 7(1), 4. https://doi.org/10.1186/s40959-021-00090-2
van der Linde, D., van Hagen, I., Veen, K., Zuetenhorst, H., & van Dalen, B. (2023). Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 31(3), 103–108. https://doi.org/10.1007/s12471-022-01734-3
Shehata, I. M., Odell, T. D., Elhassan, A., Urits, I., Viswanath, O., & Kaye, A. D. (2021). Global Longitudinal Strain: Is It Time to Change the Preoperative Cardiac Assessment of Oncology Patients?. Oncology and therapy, 9(1), 13–19. https://doi.org/10.1007/s40487-020-00134-0
Marwick T. H. (2022). Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment. Current oncology reports, 24(6), 687–694. https://doi.org/10.1007/s11912-022-01242-y
Shiino, K., Yamada, A., Ischenko, M., Khandheria, B. K., Hudaverdi, M., Speranza, V., Harten, M., Benjamin, A., Hamilton-Craig, C. R., Platts, D. G., Burstow, D. J., Scalia, G. M., & Chan, J. (2017). Intervendor consistency and reproducibility of left ventricular 2D global and regional strain with two different high-end ultrasound systems. European heart journal. Cardiovascular Imaging, 18(6), 707–716. https://doi.org/10.1093/ehjci/jew120
Medvedofsky, D., Maffessanti, F., Weinert, L., Tehrani, D. M., Narang, A., Addetia, K., Mediratta, A., Besser, S. A., Maor, E., Patel, A. R., Spencer, K. T., Mor-Avi, V., & Lang, R. M. (2018). 2D and 3D Echocardiography-Derived Indices of Left Ventricular Function and Shape: Relationship With Mortality. JACC. Cardiovascular imaging, 11(11), 1569–1579. https://doi.org/10.1016/j.jcmg.2017.08.023
Ebaid, H. H., Sarhan, . R. S. R., & Mansour, A. E. (2020). Early Detection of Cardiotoxicity in patients receiving cancer Chemotherapy Using three-dimensional and Speckle Tracking Echocardiography. International Journal of the Cardiovascular Academy, 6(4), 169-175. https://doi.org/10.4103/IJCA.IJCA_43_20
Kim, H. M., Hwang, I. C., Yoon, Y. E., Park, J. B., Lee, S. P., Kim, H. K., Kim, Y. J., Lim, Y., & Cho, G. Y. (2023). Prediction of Deterioration of Left Ventricular Function Using 3-Dimensional Speckle-Tracking Echocardiography in Patients With Left Bundle-Branch Block. Journal of the American Heart Association, 12(1), e026194. https://doi.org/10.1161/JAHA.122.026194
Mirea, O., Pagourelias, E. D., Duchenne, J., Bogaert, J., Thomas, J. D., Badano, L. P., Voigt, J. U., & EACVI-ASE-Industry Standardization Task Force (2018). Variability and Reproducibility of Segmental Longitudinal Strain Measurement: A Report From the EACVI-ASE Strain
Gao, L., Lin, Y., Ji, M., Wu, W., Li, H., Qian, M., Zhang, L., Xie, M., & Li, Y. (2022). Clinical Utility of Three-Dimensional Speckle-Tracking Echocardiography in Heart Failure. Journal of clinical medicine, 11(21), 6307. https://doi.org/10.3390/jcm11216307
Mutluer, F. O., Bowen, D. J., van Grootel, R. W. J., Roos-Hesselink, J. W., & Van den Bosch, A. E. (2021). Left ventricular strain values using 3D speckle-tracking echocardiography in healthy adults aged 20 to 72 years. The international journal of cardiovascular imaging, 37(4), 1189–1201. https://doi.org/10.1007/s10554-020-02100-3
O'Driscoll, P., Gent, D., Corbett, L., Stables, R., & Dobson, R. (2024). Feasibility of three dimensional and strain transthoracic echocardiography in a single-centre dedicated NHS cardio-oncology clinic. Echo research and practice, 11(1), 27. https://doi.org/10.1186/s44156-024-00063-y
Copyright (c) 2026 Marta Kowalska, Kinga Popielarska, Marta Opalińska-Kubowicz, Zuzanna Musialska, Yuliia Protsenko, Magdalena Barczewska, Anna Marczak, Dominika Bieszczad, Olga Stadnicka, Marzena Swojnóg, Adam Mazurek, Justyna Drożdżał, Oliwia Barańska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
